Press release
DERMA-CODE Introduces Precision-Engineered Formulations Uniting NAD+, PDRN, and Peptides in a Stabilized System
Palm Springs, California, October 2025 - DERMA-CODE announces a new chapter in molecular skincare science with the launch of its precision-engineered formulations that unite NAD+, PDRN (Sodium DNA), and six peptides in one synergistic system. Designed for visible renewal and long-term skin support, the line represents a major advancement in active ingredient stability, molecular delivery, and formulation integrity.The debut includes two products: the DERMA-CODE PDRN + NAD+ Facial Serum and the DERMA-CODE Universal Barrier Support Moisturizer. Each can be used individually or layered together for enhanced performance, making them adaptable to any existing skincare routine.
A Scientific Milestone in Modern Skincare
Until now, combining NAD+, PDRN, and bioactive peptides within a single stabilized formulation has been a challenge due to oxidation sensitivity, peptide reactivity, and molecular instability. DERMA-CODE achieved what no other brand has: a controlled molecular environment that stabilizes all three actives simultaneously while preserving their structure, potency, and functional integrity.
This stability is achieved through a proprietary molecular suspension and controlled-oxygen process that maintains ingredient harmony from formulation to final fill, an approach rarely seen outside pharmaceutical and biotechnology applications. This innovation resulted in the DERMA-CODE Tri-Active System, a molecular framework designed to complement the skin's biology rather than override it.
• NAD+ (Nicotinamide Adenine Dinucleotide): A coenzyme essential to visible repair and resilience, supporting the skin's natural energy and renewal cycle.
• PDRN (Sodium DNA): A nucleic acid fraction derived from salmon DNA that promotes smoother texture and balanced tone.
• Six Peptides: Bioactive amino acid complexes that assist firmness, elasticity, and barrier support.
Each ingredient is selected for its compatibility within the system and verified for functional stability through internal testing.
Precision Delivery and Molecular Compatibility
While most large-molecule actives remain on the skin's surface, DERMA-CODE engineered a delivery framework that supports real absorption and measurable performance. Each formula is designed around a molecular weight range of 50-300 kDa, optimizing diffusion through the upper epidermal layers while maintaining molecular stability.
This system uses a controlled molecular suspension and polarity-balanced carrier matrix, allowing NAD+, PDRN, and peptides to move efficiently within the skin's natural lipid structure. It also employs viscosity modulation technology, ensuring that active ingredients penetrate rather than sit on the surface, delivering targeted results without barrier disruption.
Unlike conventional blends that simply combine actives in water-based emulsions, the DERMA-CODE Tri-Active System creates a true biological synergy that enables actives to remain stable, bioavailable, and functionally active until delivery. DERMA-CODE employs six clinically validated peptides at functional concentrations within this molecular framework. Each peptide was selected for compatibility, stability, and purpose, ensuring visible results through precision, not volume.
Formulas boasting dozens of peptides at trace levels are often decorative rather than functional. Peptide efficacy depends on sequence integrity and concentration balance, not numerical count. While other formulas may reference NAD+, PDRN, and peptides together, none have achieved simultaneous stabilization and delivery within a true serum and moisturizer system. Most exist only as lightweight toners or essence waters, where active molecules remain unstable and functionally inactive upon application.
This delivery logic defines the DERMA-CODE Tri-Active System, a biologically functional network that ensures every molecule reaches its intended target and performs as designed.
Controlled Formulation and Verified Stability
All DERMA-CODE products are developed and filled in a GMP and FDA-registered biotechnology facility under controlled environmental conditions. This process reduces oxidation, microbial exposure, and temperature variation to ensure active ingredients maintain their structure and effectiveness.
Each batch undergoes microbial testing, stability analysis, and random quality inspections before release. The result is a high-purity formula that performs consistently from the first pump to the last. Both products are fragrance-free, colorant-free, and produced in limited batches to uphold strict quality control standards.
Packaging That Protects What Matters
The PDRN + NAD+ Facial Serum is packaged in an airless, UV-protected frosted glass bottle to prevent oxidation and light degradation. The Universal Barrier Support Moisturizer is sealed in an opaque protective tube that shields sensitive ingredients while maintaining hygienic dispensing. Each delivery system was chosen for preservation, not appearance, reflecting DERMA-CODE's science-before-style philosophy.
Transparency Without Hype
DERMA-CODE was created for those who read ingredient lists, question formulation logic, and demand truth from their skincare.
"Our ingredient callouts exist for transparency, not hype," said Gabrielle, founder of DERMA-CODE. "Every ingredient is there for a purpose, backed by formulation evidence and verified compatibility. We do not add actives for decoration, we include them for performance."
Limited Availability and Waitlist Access
To maintain quality control, DERMA-CODE will release its first production run in limited quantities. Customers can join the official waitlist at www.derma-code.com for early access before the public release in November 2025.
About DERMA-CODE
DERMA-CODE is a U.S.-based skincare company headquartered in Palm Springs, California, dedicated to molecular precision, transparency, and trust. Each formula is manufactured in China in a GMP and FDA-registered biotechnology facility under sterile, controlled conditions compliant with U.S. FDA MoCRA regulations. The brand's mission is to merge biotechnology with everyday skincare through evidence-based formulations that maintain their molecular integrity from production to application.
Press Contact
info@derma-code.com
DERMA-CODE LLC
Palm Springs, CA 92262 USA
www.derma-code.com
Brand Signature
We earn trust through results, not promises.
DERMA-CODE LLC
Palm Springs, CA 92262 USA
Email: info@derma-code.com
Website: www.derma-code.com
Press Contact: Gabrielle, Founder
DERMA-CODE is a U.S.-based skincare company headquartered in Palm Springs, California, dedicated to molecular precision, transparency, and trust. Each formula is developed through biotechnology and verified for stability, safety, and functional integrity.
DERMA-CODE merges advanced molecular science with everyday skincare through evidence-based formulations that maintain their integrity from production to application. The brand focuses on transparency, formulation accuracy, and visible results through verified testing and regulatory compliance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release DERMA-CODE Introduces Precision-Engineered Formulations Uniting NAD+, PDRN, and Peptides in a Stabilized System here
News-ID: 4230559 • Views: …
More Releases for NAD+
Test NAD+ at Home: CELFULL Launches Science-Backed Aging Tracker
Coral Springs, FL - Aug 20, 2025 - At the end of 2020, CELFULL launched the Hebe Youth Project, the world's first large-scale, real-world NAD+ supplementation study. The initiative aims to establish accurate baseline NAD+ values, assess aging levels, explore optimal supplementation strategies, and quantify the relationship between NAD+ and aging.
Image: https://www.globalnewslines.com/uploads/2025/08/4367a5b1043ece7e6611155ff767e121.jpg
BRET sensor correlation, analyte colors, and molecular interaction.
Over five years, CELFULL has collected more than 100,000 samples, establishing precise…
Nicotinamide Adenine Dinucleotide (NAD) Industry Outlook | Growth Opportunities …
Market Size and Growth
✦ The market was valued at approximately, reflecting strong, sustained growth. at a CAGR of 11.25 % during the forecast period (2024-2031)
✦ The driving force behind this expansion is a combination of surging global demand, technological advancements, and significant investments in new infrastructure projects.
Mergers and acquisition
ChromaDex rebranded as Niagen Bioscience in March 2025 to emphasize its focus on NAD+ science and its flagship ingredient, Niagen.
In early…
NAD-based Anti-Aging Market Surges as Next-Gen Liposomal NMN and NAD Nasal Spray …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores)…
NAD in Georgia Launches Exclusive BR+NAD Outpatient Treatment Offer
NAD in Georgia introduces BR+NAD, an innovative 10-day outpatient treatment for addiction with a 90% effectiveness rate. Unlike traditional inpatient programs, it offers faster recovery, minimal side effects, and reduced costs ($12,500 vs. $27,000+). This holistic therapy, including NAD+ treatment, supports detox, cravings reduction, and brain health restoration, providing a sustainable, cost-effective solution for long-term recovery.
Alpharetta, GA - May 14, 2025 - NAD in Georgia proudly unveils its BR+NAD outpatient…
NAD+ Enhancer Market: An Extensive Analysis Predicts Significant Future Growth
NAD+ Enhancer Market Overview :
The NAD+ Enhancer Market is significant growth determined by increasing consumer awareness of cellular health, aging-related research, and longevity-focused nutraceuticals. NAD+ (Nicotinamide Adenine Dinucleotide) plays a crucial role in cellular metabolism and energy production, making NAD+ enhancers highly sought after in anti-aging, cognitive health, and sports performance supplements. Advancements in biotechnology and clinical studies supporting NAD+ restoration's benefits have further fueled market expansion. Key players are…
NAD Electronics Introduces the C 379 HybridDigital DAC Amplifier
The new addition to the Classic Series combines innovation and value to deliver refined performance and sound quality.
MAY 2, 2024 - MUNICH, GERMANY - NAD Electronics, a leading manufacturer in high-performance audio, today announces the launch of its new Classic Series amplifier, the C 379 HybridDigital DAC Amplifier at the HIGH END Munich International Audio Show. The C 379 builds on NAD's commitment to innovation and value-driven performance with a…